[Flecainide acetate in the acute and medium-term prophylactic treatment of 2 cases of ectopic atrial tachycardia].
The aim of this study is to evaluate the efficacy of flecainide acetate, which was administered intravenously, to induce cardioversion in 2 female patients of 48 and 76 years, with ectopic atrial tachycardia. Besides the clinical examination, ECG monitoring by radiotelemetry, chest x-ray, echocardiographic examination, thyroid tests and other routine hematochemical tests, we carried out an endocavitary electrophysiologic study, followed by pharmacologic tests in series: propranolol (5 mg/5 min iv), verapamil (5 mg/5 min iv) and flecainide (1.5 mg/kg/15 min iv). We confirmed the presumptive diagnosis of ectopic atrial tachycardia and that, among all the drugs tested, flecainide acetate was the only one restoring the sinus rhythm. In a medium-term follow-up, during which the patients were treated with flecainide, 100 mg twice-a-day, we didn't notice relapse of the tachycardia and the patients tolerated the drug well.
Tognarini
S
S
Pardini
E
E
D000368:Aged; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D005424:Flecainide / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D013612:Tachycardia, Ectopic Atrial / Q000188:drug therapy* / Q000503:physiopathology; D013617:Tachycardia, Supraventricular
D005424:Flecainide
Trattamento acuto e profilassi a medio termine con flecainide acetato in 2 casi di tachicardia atriale ectopica.